Medicine guide
Granupas (previously Para-aminosalicylic acid Lucane)
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Para-aminosalicylic acid
- Made by
- Eurocept International B. V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Granupas is indicated for use as part of an appropriate combination regimen for multi-drug resistant tuberculosis in adults and paediatric patients from 28 days of age and older when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see section 4.4). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
Details
| Made by | Eurocept International B. V. |
|---|---|
| Active substance | Para-aminosalicylic acid |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J04AA01 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2014-04-07 |
| Last updated by the regulator | 2026-01-05 |
| EMA product number | EMEA/H/C/002709 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).